PubMed

INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling.

Filleur S, Hirsch J, Wille A, Schön M, Sell C, Shearer MH, Nelius T, Wieland I.

Cancer Cell Int. 2009 Nov 11;9:28.PMID: 19906297 [PubMed]Related articlesFree article

Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer.

Röpke A, Buhtz P, Böhm M, Seger J, Wieland I, Allhoff EP, Wieacker PF.

Oncogene. 2005 Oct 6;24(44):6667-75.PMID: 16007164 [PubMed - indexed for MEDLINE]Related articles

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J.

BMC Cancer. 2009 Jun 7;9:173.PMID: 19500415 [PubMed - indexed for MEDLINE]Related articlesFree article

Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.

Uysal-Onganer P, Kawano Y, Caro M, Walker MM, Diez S, Darrington RS, Waxman J, Kypta RM.

Mol Cancer. 2010 Mar 10;9(1):55. [Epub ahead of print]PMID: 20219091 [PubMed - as supplied by publisher]Related articles

Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.

Wang P, Ma Q, Luo J, Liu B, Tan F, Zhang Z, Chen Z.

Cancer Invest. 2009 May;27(4):369-75.PMID: 19266349 [PubMed - indexed for MEDLINE]Related articles

Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells.

Floryk D, Thompson TC.

Int J Cancer. 2008 Nov 15;123(10):2294-302.PMID: 18712736 [PubMed - indexed for MEDLINE]Related articles

Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.

Neuwirt H, Puhr M, Santer FR, Susani M, Doppler W, Marcias G, Rauch V, Brugger M, Hobisch A, Kenner L, Culig Z.

Am J Pathol. 2009 May;174(5):1921-30. Epub 2009 Mar 26.PMID: 19342366 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.

Kobayashi T, Shimizu Y, Terada N, Yamasaki T, Nakamura E, Toda Y, Nishiyama H, Kamoto T, Ogawa O, Inoue T.

Prostate. 2010 Feb 1. [Epub ahead of print]PMID: 20127734 [PubMed - as supplied by publisher]Related articles

Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.

Zolochevska O, Figueiredo ML.

Prostate. 2009 Oct 1;69(14):1586-97.PMID: 19585490 [PubMed - indexed for MEDLINE]Related articles

Ectopic expression of DICE1 suppresses tumor cell growth.

Wieland I, Sell C, Weidle UH, Wieacker P.

Oncol Rep. 2004 Aug;12(2):207-11.PMID: 15254679 [PubMed - indexed for MEDLINE]Related articles

Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells.

Kunnev D, Ivanov I, Ionov Y.

BMC Cancer. 2009 Sep 8;9:318.PMID: 19737411 [PubMed - indexed for MEDLINE]Related articlesFree article

3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.

Vivar OI, Lin CL, Firestone GL, Bjeldanes LF.

Biochem Pharmacol. 2009 Sep 1;78(5):469-76. Epub 2009 May 9.PMID: 19433067 [PubMed - indexed for MEDLINE]Related articles

Regulation of growth hormone receptors in human prostate cancer cell lines.

Bidosee M, Karry R, Weiss-Messer E, Barkey RJ.

Mol Cell Endocrinol. 2009 Oct 15;309(1-2):82-92. Epub 2009 Jun 18.PMID: 19540305 [PubMed - indexed for MEDLINE]Related articles

Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.

Pang B, Zhang H, Wang J, Chen WZ, Li SH, Shi QG, Liang RX, Xie BX, Wu RQ, Qian XL, Yu L, Li QM, Huang CF, Zhou JG.

Prostate. 2009 Aug 1;69(11):1176-87.PMID: 19415690 [PubMed - indexed for MEDLINE]Related articles

[Effect of aurora A on carcinogenesis of human prostate cancer]

Qu Y, Zhang L, Mu DZ, Huang X, Wei DP, Zhao FY, Liu BL.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jan;39(1):1-5. Chinese. PMID: 18390187 [PubMed - in process]Related articles

Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.

Torosyan Y, Simakova O, Naga S, Mezhevaya K, Leighton X, Diaz J, Huang W, Pollard H, Srivastava M.

Int J Cancer. 2009 Dec 1;125(11):2528-39.PMID: 19610065 [PubMed - indexed for MEDLINE]Related articles

Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.

Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV.

Mol Cancer Ther. 2010 Jan;9(1):33-45. Epub 2010 Jan 6.PMID: 20053773 [PubMed - in process]Related articles

Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.

Li H, Qi Y, Li C, Braseth LN, Gao Y, Shabashvili AE, Katovich MJ, Sumners C.

Mol Cancer Ther. 2009 Dec;8(12):3255-65. Epub .PMID: 19996275 [PubMed - in process]Related articles

Differential expression of new splice variants of the neurotensin receptor 1 gene in human prostate cancer cell lines.

Almeida TA, Rodriguez Y, Hernández M, Reyes R, Bello AR.

Peptides. 2010 Feb;31(2):242-7. Epub 2009 Dec 14.PMID: 20018219 [PubMed - in process]Related articles

Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling.

Chesnokov V, Sun C, Itakura K.

Cancer Cell Int. 2009 Sep 10;9:25.PMID: 19744341 [PubMed]Related articlesFree article